Bank of America adjusted its price target and rating for PTC Therapeutics.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America adjusted its price target and rating for PTC Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
PTC Therapeutics
pharmaceutical company
Nothing else this week.
Related events
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
- Market comparison of two biopharmaceutical companies, PTC Therapeutics and Senti Biosciences.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.
- Bank of America raised its rating and price target for a company due to promising CPU opportunities.
- Financial firms including Bank of America, Morgan Stanley, and Truist Financial adjusted price targets and ratings for Somnigroup International Inc.